Medikinet CR 40mg capsules contain methylphenidate hydrochloride in a controlled-release (biphasic) formulation. It is indicated as part of a comprehensive treatment programme for ADHD in children (6 years and older), adolescents, and adults when remedial measures alone are insufficient.

How Medikinet CR 40mg Works Methylphenidate increases dopamine and norepinephrine levels in the brain by blocking their reuptake. The CR formulation provides an immediate initial release followed by a slower extended release, offering consistent symptom control for approximately 8 hours.

Main Uses:

• Attention Deficit Hyperactivity Disorder (ADHD)
• Improves concentration, attention span, and impulse control
• Reduces hyperactivity and restlessness

Dosage and Administration Medikinet CR is taken once daily in the morning. The 40mg strength is a common maintenance dose. Capsules can be swallowed whole or opened and the contents sprinkled on soft food (e.g., yogurt or apple sauce) if swallowing is difficult. Do not crush or chew the beads. Dose must be individualized and regularly reviewed by a specialist.

Quality and Formulation Medikinet CR 40mg is manufactured by Medice (Germany) under strict GMP standards. Each capsule contains a mixture of immediate-release and prolonged-release methylphenidate beads.

Warnings and Precautions Medikinet CR 40mg is a Schedule II controlled substance with potential for abuse, dependence, and diversion. Serious risks include cardiovascular effects (increased heart rate and blood pressure), psychiatric symptoms, and growth suppression in children.

Common side effects: decreased appetite, insomnia, headache, dry mouth, anxiety, and stomach pain. Contraindicated in patients with heart disease, glaucoma, hyperthyroidism, severe hypertension, or history of substance abuse. Regular monitoring of blood pressure, heart rate, height, and weight is required.

Not recommended during pregnancy or breastfeeding. May impair driving and operating machinery.